#evaluate(de(' #AdditionalMetaTags# '))#
At Nagi Bioscience we develop innovative laboratory equipment that allows replacing animal testing with assays conducted on micro-organisms. Achieve unprecedented levels of scalability and reproducibility with our newly launched product SydLab" One: the first all-in-one laboratory device capable of performing end-to-end bioassays and high-content screening of drugs and chemicals on micro-organisms in a fully automated and standardized way.
Obtain accurate full-organism data without animal testing. Unlock the potential of micro-organisms in your lab seamlessly with SydLab" One.
New Startup Innovation Projects set to advance their technologies (startupticker.ch)
23 start-ups qualified for the second stage of the Innosuisse Scale-up Coaching program (startupticker.ch)
Medtechs expand their global footprint with key partners (startupticker.ch)
Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)
Nagi Bioscience brings SydLab platform to five leading academic labs (startupticker.ch)
The most promising Swiss biotech startups and scale-ups of 2024, according to investors (TOP 100)
Swiss life science startups headed for San Diego (startupticker.ch)
A decent representation at BIO-Europe (startupticker.ch)
Nagi Bioscience raises CHF 12.4M to open new markets (startupticker.ch)
Nagi Bioscience secures CHF 12.4 Million investment in Series A round to revolutionize animal testing alternatives (venturelab.swiss)
New bearers of the Innosuisse Certificate ready for the next level (startupticker.ch)
Nagi Bioscience enters the laboratory equipment market (startupticker.ch)
Swiss startups prepare to visit the US East Coast (startupticker.ch)
The 18 most promising biotech startups, according to investors (TOP 100)
Ten startups to explore India (startupticker.ch)
After successful service projects, Nagi Bioscience eyes product launch (startupticker.ch)
Finalists of the W. A de Vigier revealed (startupticker.ch)
17 deep-dech start-ups shortlisted for the W.A. de Vigier Award (startupticker.ch)
Good Morning Startup: Credit Suisse investors and TOP 100 startups connect over breakfast (venturelab.swiss)
10 Swiss Biotech Startups to Watch in 2020 (venturelab.swiss)
Nagi Bioscience secures 12.4M CHF investment with an oversubscribed Series A funding round
Use of our technology for toxicology validated with Bayer CropScience (results co-published)
Beta Testing Program completed
Beta Product finalized
Core Patents granted
Get to know Nagi - From a vision to a reality
Kicking forward alternatives to animal testing
Nagi Bioscience at the TOP 100 Swiss Startup Award 2020